Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

• • Aug 31, 2009
  • CRESTOR® reduced risk of cardiovascular events in elderly patients in new analysis of JUPITER  
• • Aug 31, 2009
  • AstraZeneca announces FDA acceptance of New Drug Application for VIMOVO  
• • Aug 30, 2009
  • Phase III head to head trial showed ticagrelor reduced cardiovascular death and heart attacks over clopidogrel in acute coronary syndromes patients  
• • Aug 26, 2009
  • Governor Markell, Transportation Secretary Wicks, Congressman Castle promote “clean and healthy commuting” by biking to work  
• • Aug 14, 2009
  • ONGLYZA™ (saxagliptin), a new treatment for type 2 diabetes mellitus in adults, now available in U.S. pharmacies  
• • Aug 4, 2009
  • Project Zero Delay accelerates drug’s path to clinical trial  
• • Aug 3, 2009
  • AstraZeneca sponsors 2009 Summer National Senior Games  
• • Jul 31, 2009
  • U.S. Food and Drug Administration approves ONGLYZA™ (saxagliptin) for the treatment of type 2 diabetes mellitus in adults  
• • Jul 31, 2009
  • AstraZeneca and the Artery Explorer take California residents on a virtual journey through the arteries  
• • Jul 30, 2009
  • AstraZeneca PLC second quarter and half year results 2009  

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed